Skip to Content
Merck
CN
  • Carbapenemase producing Enterobacteriaceae in Belgian nursing homes: myth or real danger?

Carbapenemase producing Enterobacteriaceae in Belgian nursing homes: myth or real danger?

Acta clinica Belgica (2014-03-19)
V S M Saegeman, M Ntoumpanaki, L Niclaes, A Schuermans
ABSTRACT

Prevalence of carbapenemase-producing Enterobacteriaceae (CPE) is increasing both in hospitals and in the community. In this point prevalence study, rectal CPE colonization was investigated among 150 nursing home residents. No CPE were detected. Epidemiological data directly linked with CPE colonization in community and nursing home settings are currently lacking. Further research will show whether the preventive measures taken, including a strong focus on standard precautions, a dedicated isolation policy, and antibiotic restriction will retain CPE to invade nursing homes.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Penicillinase from Bacillus cereus, lyophilized, powder, white, ~13 U/mg
Sigma-Aldrich
Penicillinase from Bacillus cereus, lyophilized powder, ≥1500.00 units/mg protein (using benzylpenicillin)
Sigma-Aldrich
β-Lactamase from Enterobacter cloacae, Type IV, lyophilized powder, 0.2-0.6 units/mg protein (using benzylpenicillin)
Sigma-Aldrich
β-Lactamase, recombinant, expressed in E. coli
Sigma-Aldrich
β-Lactamase from Pseudomonas fluorescens, lyophilized powder, recombinant, expressed in E. coli
Sigma-Aldrich
β-Lactamase Blend, recombinant, expressed in E. coli